Chagas' heart disease and the autonomic nervous system

International Journal of Cardiology

Volumn 66, Issue 2, 1998, Pages 123-127

  Dávila, Diego F ^a   Inglessis, George ^a   Mazzei De Dávila, Carmen A ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

Author keywords

Autonomic abnormalities; Chagas' disease

Indexed keywords

DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROHORMONE;

AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; CHAGAS DISEASE; CHOLINERGIC SYSTEM; CONGESTIVE HEART FAILURE; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HUMAN; PRIORITY JOURNAL; REVIEW; SYMPATHETIC FUNCTION; TRYPANOSOMA CRUZI;

AUTONOMIC NERVOUS SYSTEM; CHAGAS CARDIOMYOPATHY; DISEASE PROGRESSION; HUMANS; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0032582192     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00212-5     Document Type: Review

References (63)

1. [1] Rossi MA, Bestetti RB. The challenge of chagasic cardiomyopathy: The pathologic role of autonomic abnormalities, autoimmune mechanisms and microvascular changes and therapeutic implications. Cardiology 1995;86:1-7.
2. [2] Oliveira JSMA. Natural model of intrinsic heart nervous system denervation: Chagas' cardiopathy. Am Heart J 1985;110:1092-8.
3. [3] Koberle F. Pathogenesis of Chagas' disease. Ciba Found Symp 1974;20:137-52.
4. [4] Mott K, Hagstrom JWC. The pathologic lesions of the cardiac autonomic nervous system in chronic chagasic myocarditis. Circulation 1965;31:273-6.
5. [5] Neto JA, Gallo Jr L, Manco JC, Rassi A, Amorim DS. Postural reflexes in chronic Chagas heart disease: heart rate and arterial pressure responses. Cardiology 1975;60:343-57.
6. [6] Amorim DS, Manco DS, Gallo JR, Marin-Neto JA. Chagas' heart disease as an experimental model to study cardiac autonomic function in man. Mayo Clin Proc 1982;57((Suppl)):46-62.
7. [7] Junqueira Jr LF, Gallo Jr L, Manco JC, Marin-Neto JA, Amorim DS. Subtle cardiac autonomic impairment in Chagas' disease detected by baroreflex sensitivity testing. Braz J Med Biol Res 1985;18:171-8.
8. [8] Marin-Neto JA, Maciel BC, Gallo Jr L, Junqueira Jr LF, Amorim DS. Effect of parasympathetic impairment on the haemodynamic response to handgrip in Chagas' disease. Br Heart J 1986;55:204-10.
9. [9] Gallo Jr L, Morelo Filho J, Maciel BC, Marin-Neto JA, Martins LEB, Lima Filho EC. Functional evaluation of sympathetic and parasympathetic system in Chagas' disease using dynamic exercise. Cardiovasc Res 1987;21:922-7.
10. [10] Junqueira Jr LF. Ambulatory assessment of cardiac autonomic function in Chagas' heart disease patients based on indexes of R-R interval variation in the Valsalva maneuver. Braz J Med Biol Res 1990;23:1091-102.
11. [11] Amorim DS, Chambers RJ, Beck W, Somers K, Manco JC, Gallo Jr L. Comparative observations of the impairment of autonomic responses in chronic Chagas' heart disease and in African myocardiopathies. Cardiology 1970;55:321-6.
12. [12] Davila DF, Rosell O, Donis JH. Cardiac parasympathetic abnormalities: Cause or consequence of Chagas' heart disease? Parasitol Today 1989;5:327-9.
13. [13] Davila DF, Donis JH, Torres A, Gotteberg CF, Rossell O. Cardiac parasympathetic innervation in Chagas' heart disease. Med Hypotheses 1991;35:80-4.
14. [14] Davila DF, Donis JH, Torres A. Chagas' heart disease and neuropathy. Am Heart J 1992;124:1665-6.
15. [15] Oliveira JSM, Marin-Neto JA. Editorial note: parasympathetic impairment in Chagas' disease. Cause or consequence? Int J Cardiol 1988;21:153-6.
16. [16] Davila DF, Bellabarba G, Donis JH, et al. Cardiac autonomic control mechanisms in Chagas' heart disease. Therapeutic implications. Med Hypotheses 1993;40:33-7.
17. [17] Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992;20:248-54.
18. [18] Iosa D, Dequattro V, De-Ping LD, Elkayam U, Caeiro T, Palmero H. Pathogenesis of cardiac neuro-myopathy in Chagas' disease and the role of the autonomic nervous system. J Auton Nervous Syst 1990;30:S83-8.
19. [19] Davila DF, Donis JH, Navas M, Fuenmayor AJ, Torres A, Gottberg CF. Response of heart rate to atropine and left ventricular function in Chagas' heart disease. Int J Cardiol 1988;21:143-56.
20. [20] Fuenmayor AJ, Fuenmayor AM, Donis JH, et al. The valsalva maneuver: a test of the functional state of cardiac innervation in chagasic myocarditis. Int J Cardiol 1988;18:351-6.
21. [21] Casado J, Davila DF, Donis JH, et al. Electrocardiographic abnormalities and left ventricular systolic function in Chagas' heart disease. Int J Cardiol 1990;27:55-62.
22. [22] Eckberg DL, Drabinsky M, Braunwald E. Defective parasympathetic control in patients with heart disease. New Engl J Med 1971;285:877-83.
23. [23] Goldstein RE, Davis GD, Stamperf M, Epstein SE. Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circ Res 1975;36:571-8.
24. [24] Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995;92:3206-11.
25. [25] Eaton GM, Cody RJ, Nunziata E, Binkley PF. Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure. Circulation 1995;92:555-61.
26. [26] Kinugawa T, Dibner-Dunlap ME. Altered vagal and sympathetic control of heart rate in left ventricular dysfunction and heart failure. Am J Physiol (Regulatory Integrative Comp Physiol) 1995;268:R316-.
27. [27] Davila DF, Donis JH, Torres A, et al. Apical left ventricular aneurysms and cardiac parasympathetic innervation in Chagas' heart disease. Med Hypotheses 1992;42:53-6.
28. [28] Guzetti S, Iosa D, Pecis M, Bonura L, Prosdocini M, Malliani A. Impaired heart rate variability in patients with chronic Chagas' disease. Am Heart J 1991;121:1727-8.
29. [29] Carrasco H, Jugo D, Medina R, Castillo C, Miranda P. Electrocardiograma de alta resolución y variabilidad de la frecuencia cardiaca en pacientes chagásicos crónicos. Arch Inst Cardiol Mex 1997;67:277-85.
30. [30] Iosa D, De Quattro V, De-Ping L, Elkayam U, Palmero H. Plasma norepinephrine in Chagas' cardioneuropathy: a marker of progressive dysautonomia. Am Heart J 1980;117:882-7.
31. [31] Haskings GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence for increased overall and cardiorenal sympathetic activity. Circulation 1986;73:615-62.
32. [32] Harris P. Evolution and the cardiac patient. Cardiovasc Res 1983;17:248-54.
33. [33] Hagar J, Rahimtoola SH. Chagas' heart disease. Current Problems Cardiol 1995;20:825-8.
34. [34] Morris SA, Tanowitz HB, Wittner M, Bilezikian JP. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation 1990;82:1900-9.
35. [35] Bestetti RB, Coutinho-Netto J, Staibno L, Pinto LZ, Muccillo G, Oliveira JSM. Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease. Cardiology 1995;86:202-6.
36. [36] Polinsky RJ. Neurochemical and pharmacologic abnormalities in chronic autonomic failure syndromes. In: Low PA, editor, Clinical Autonomic Disorders. Boston: Little, Brown and Company, 1993, pp. S37-S48.
37. [37] McLeod JG. Autonomic dysfunction in peripheral nerve disease. In: Bannister G, Mathias CJ, editors. Autonomic Failure. A Text Book of Clinical Disorders of the Autonomic Nervous System. New York: Oxford University Press, 1992, pp. 539-681.
38. [38] Davila DF, Bellabarba G, Hernandez L, et al. Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagas' heart disease. Int J Cardiol 1995;52:145-51.
39. [39] Bellabarba G, Davila DF, Torres A, et al. Plasma renin activity in chagasic patients with and without congestive heart failure. Int J Cardiol 1994;47:5-11.
40. [40] Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S, for the SOLVD Investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 1990;82:1727-9.
41. [41] Jonhson G, Carson P, Francis GS, Cohn JN, for the V-Heft VA Cooperative studies Group. Influence of prerandomization (Baseline) variables on mortality and on the reduction of mortality by enalapril: Veterans Affairs Cooperative Study on Vasodilator Therapy for Heart Failure (V-HeFT II). Circulation 1993;87:VI-32-VI-39.
42. [42] Francis GS, Cohn JN, Johnson G, et al. for the V-HeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity, and congestive heart failure: Relations to survival and the effects of therapy in V-HeFT II. Circulation 1993;87:VI-40-VI-48.
43. [43] Gheorghiade M, Ferguson DW. Digoxin. A neurohormonal modulator in heart failure? Circulation 1991;84:2181-266.
44. [44] Khoury AM, Davila DF, Bellabarba G, et al. Acute effects of digitalis and enalapril on the neurohormonal profile of chagasic patients with severe congestive heart failure. Int J Cardiol 1996;57:21-9.
45. [45] Manco JC, Gallo Jr L, Godoy RA, et al. Acute hemodynamic effects of digitalis on chronic Chagas' disease. Arq Bras Cardiol 1974;27:25-35.
46. [46] Roberti RR, Martinez EE, Andrade JL, et al. Chagas cardiomyopathy and captopril. Europ Heart J 1992;13:966-70.
47. [47] Rossi L. Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment. Cardiovasc Pathol 1996;5:233-9.
48. [48] Kamran M, Salomone O, Caforio ALP, et al. Human chagasic disease is not associated with an antiheart humoral response. Am J Cardiol 1997;79:1135-6.
49. [49] Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy P. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. New Engl J Med 1997;336:1350-6.
50. [50] Cohn JN. Structural basis of heart failure: Ventricular remodeling and its pharmacological inhibition. Circulation 1995;91:2504-7.
51. [51] Lauer MS, Evans JC, Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham heart study). Am J Cardiol 1992;70:1180-4.
52. [52] Fuster V, Gersh BJ, Guliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-31.
53. [53] White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
54. [54] Carrasco HA, Parada H, Guerrero L, Duque M, Durán D, Molina C. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in Chagas' disease. Int J Cardiol 1994;43:27-8.
55. [55] Bestetti RB, Dalbo CMR, Arruda CA, Filho DC, Freitas OC. Predictors of sudden cardiac death for patients with Chagas' disease: A hospital-derived cohort study. Cardiology 1996;86:481-7.
56. [56] Mady C, Antonelli Cardoso RH, Pereira Barreto AC, Lemos da Luz P, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994;90:3098-102.
57. [57] Acquatella H, Catalioti F, Mancebo JRG, Davalos Villalobos L. Long term control of Chagas' disease in Venezuela: Effects on serologic findings, electrocardiographic abnormalities and clinical outcome. Circulation 1987;76:556-62.
58. [58] Hagar JM, Rahimtoola S. Chagas heart disease in the United States. New Engl J Med 1991;325:763-8.
59. [59] Bestetti R, Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol 1997;60:87-93.
60. [60] The SOLVD investigators. Adverse effects of enalapril in the studies of left ventricular systolic dysfunction (SOLVD). Am Heart J 1996;131:350-5.
61. [61] Fowler MB, Vagelos RH, Schroeder JS et al. Comparison of high versus low dose enalapril on clinical outcomes and neuroendocrine activation in advanced heart failure. Circulation 1997;96:SI-20 (Abst).
62. [62] One year mortality prognosis in heart failure: A neural network approach based on echocardiographic data. J Am Coll Cardiol 1995;26:1586-93.
63. [63] Bestetti RB, Rossi MA. A rationale approach for mortality risk stratification in Chagas' heart disease. Int J Cardiol 1997;58:199-209.